In the Media
InMed CEO says ‘tremendous potential’ for its cannabinoid-based therapy to treat glaucoma
InMed Pharmaceuticals Inc (CSE:IN) (OTCMKTS:IMLFF) CEO Eric Adams sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. In this interview,...
Source: Proactive Investors